Astera Labs stock is overvalued with a Value Score of F, underperforming and facing competition.

From Nasdaq: 2025-03-21 12:48:00

Astera Lab (ALAB) shares are currently overvalued with a Value Score of F. The forward 12-month Price/Sales is 15.59X, higher than the industry average of 7.09X. ALAB underperformed the Computer & Technology sector and Electronics – Semiconductors industry, with a 48.3% decline attributed to gross margin concerns.

ALAB faces competition from Broadcom (AVGO) and others, impacting its financial performance. Despite a strong product portfolio, ALAB’s stretched valuation remains a concern. Investors may consider waiting for a more favorable entry point to accumulate ALAB stock.

ALAB expects strong growth in 1Q25, driven by AI-related products and expanding customer base. Revenues are projected between $151 million and $155 million, with non-GAAP earnings of 28-29 cents per share. Analysts estimate a year-over-year revenue increase of 134.97% and earnings growth of 180% for 1Q25.

Astera Labs collaborates with top chipmakers like NVIDIA, AMD, Micron, and Intel to enhance AI technologies. ALAB introduced Scorpio Smart Fabric for NVIDIA MGX platforms, delivering high performance and scalability. Despite competition and valuation concerns, ALAB continues to innovate and drive advancements in AI infrastructure.



Read more at Nasdaq: Should You Buy, Sell or Hold Astera Labs Stock at P/S of 15.59X?